abstract |
The present invention relates to the use of compounds that increase the extracellular levels of catecholamines, dopamine and norepinephrine, in cortical and cerebral areas of the mammalian brain, and more specifically to the use of 3-disubstituted phenyl-1-pyrrolidinoles for the treatment of disorders of the central nervous system. |